Spree Acquisition Corp 1 Limited (SHAP) Stock Fundamental Analysis

NYSE:SHAP • KYG837451023

10.91 USD
-0.02 (-0.18%)
Last: Feb 20, 2024, 08:05 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, SHAP scores 2 out of 10 in our fundamental rating. SHAP was compared to 0 industry peers in the Unkown industry. SHAP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SHAP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SHAP had positive earnings in the past year.
  • SHAP had a positive operating cash flow in the past year.
SHAP Yearly Net Income VS EBIT VS OCF VS FCFSHAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 0 1M -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA 0.83%
ROE 0.87%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHAP Yearly ROA, ROE, ROICSHAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 -0.2 -0.4 -0.6 -0.8 -1

1.3 Margins

  • SHAP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SHAP Yearly Profit, Operating, Gross MarginsSHAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, SHAP has less shares outstanding
  • SHAP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SHAP Yearly Shares OutstandingSHAP Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M 25M
SHAP Yearly Total Debt VS Total AssetsSHAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

  • SHAP has an Altman-Z score of 5.87. This indicates that SHAP is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for SHAP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.87
ROIC/WACCN/A
WACCN/A
SHAP Yearly LT Debt VS Equity VS FCFSHAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

  • SHAP has a Current Ratio of 0.14. This is a bad value and indicates that SHAP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.14 indicates that SHAP may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
SHAP Yearly Current Assets VS Current LiabilitesSHAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • SHAP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 155.86 indicates a quite expensive valuation of SHAP.
  • Compared to an average S&P500 Price/Earnings ratio of 27.05, SHAP is valued quite expensively.
Industry RankSector Rank
PE 155.86
Fwd PE N/A
SHAP Price Earnings VS Forward Price EarningsSHAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 27.02
EV/EBITDA N/A
SHAP Per share dataSHAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SHAP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Spree Acquisition Corp 1 Limited

NYSE:SHAP (2/20/2024, 8:05:29 PM)

10.91

-0.02 (-0.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)01-10
Earnings (Next)03-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap111.06M
Revenue(TTM)N/A
Net Income(TTM)1.73M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 155.86
Fwd PE N/A
P/S N/A
P/FCF 27.02
P/OCF 27.02
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)0.07
EY0.64%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY3.7%
OCF(TTM)0.4
OCFY3.7%
SpS0
BVpS19.46
TBVpS19.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 0.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 237.57%
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 5.87
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1140%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y304.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y304.49%
OCF growth 3YN/A
OCF growth 5YN/A

Spree Acquisition Corp 1 Limited / SHAP FAQ

Can you provide the ChartMill fundamental rating for Spree Acquisition Corp 1 Limited?

ChartMill assigns a fundamental rating of 2 / 10 to SHAP.


What is the valuation status for SHAP stock?

ChartMill assigns a valuation rating of 0 / 10 to Spree Acquisition Corp 1 Limited (SHAP). This can be considered as Overvalued.


What is the profitability of SHAP stock?

Spree Acquisition Corp 1 Limited (SHAP) has a profitability rating of 1 / 10.


What is the financial health of Spree Acquisition Corp 1 Limited (SHAP) stock?

The financial health rating of Spree Acquisition Corp 1 Limited (SHAP) is 5 / 10.